Two Novel Missense Tbx22 Mutations Frequently Cause Non-Syndromic Cleft Palate in Pakistani Population

Asma Basharat1, Abdul Wajid2*, Andleeb Batool1, Tayyeba Batool3, Abdul Basit4, Kamran Abbas5, Aziz Ullah1 and Mahmood Shaukat6

1Department of Zoology, Government College University, Lahore

Department of Biotechnology, Faculty of Life Sciences and Informatics, Balochistan University of Information Technology, Engineering and Management Sciences, Quetta

3Department of Biotechnology, Balochistan University of Information Technology, Engineering and Management Sciences, Quetta

4School of Biological Sciences, University of the Punjab, Lahore

5Department of Biotechnology, Virtual University of Pakistan, 1-Davis Road, Lahore

6Allama Iqbal Medical College, Lahore

Asma Basharat and Abdul Wajid contributed equally to this article.

ABSTRACT

Cleft palates (CP) are the most common birth defect with highly complex etiology, involves both genetic and environmental risk factors. In the present study, we focused on TBX22 gene, which is a major gene determinant essential to human palatogenesis. We analyzed a total of 134 DNA samples including 51 CP clinically assessed patients and 83 healthy controls. Our preliminary results revealed two novel missense substitutions i.e. P180Q in T-box domain and S328I in C-terminal of TBX22, while unrelated healthy controls revealed no sequence variants in these locations. The present report is first of its kind in Pakistani population. The findings suggest that TBX22 polymorphisms may responsible for a significant proportion of non-syndromic CP cases in Pakistani population and confirming its importance as a frequent cause of non-syndromic CP across various populations. The robustness of the association between TBX22 and CP is worth further examination in the future across different populations.

Article Information

Received 04 November 2018

Revised 12 May 2019

Accepted 11 June 2019

Available online 28 October 2022

(early access)

Published 14 November 2022

Authors’ Contribution

AU and AW designed the study. AB performed the experiment. AW, AB, TB, MS and AB analyzed and interpreted the data. AW, AB and AB prepared the final manuscript.

Key words

Non-syndromic cleft palate, TBX22, Palatogenesis, Polymorphisms, Pakistan

DOI: https://dx.doi.org/10.17582/journal.pjz/20181104181110

* Corresponding author: [email protected]

0030-9923/2023/0001-473 $ 9.00/0

Copyright 2023 by the authors. Licensee Zoological Society of Pakistan.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Orofacial cleft (OFC) is one of the most common craniofacial anomalies in human worldwide affecting children with variable phenotype. OFC is a group of conditions that include cleft palate (CP: palatoschisis) and cleft lip (CL: cheiloschisis) and both together (CL/P). The prevalence of congenital birth defect ranges from 1/500 to 1/2500 newborns depending on ethnic and geographic origins (Wehby et al., 2012). It has a complex etiology, involving both genetic as well as environmental risk factors. (Wang et al., 2016; Murray, 2002). It causes problems in speech, feeding, hearing and requiring surgical, orthodontic, dental and psychological treatments or therapies throughout childhood. Previously, major efforts have been made to map clefting genes based onanimal models and association studies conducted in various ethnic groups.

Cleft palate is basically an inherent failure of two sides of palate to merge properly, leaving a depression in the roof of mouth (Texas Department of State Health Services Birth Defects Epidemiology and Surveillance, 2005). Genetic studies have reported several candidate genes, MSX1, TGFB3, TGFA, SATB2, IRF6, AMELX and TBX22 as susceptible genes involved in the etiology of CL/P or CP (Satokata and Maas, 1994; Suphapeetiporn et al., 2007; Chen et al., 2014; Pegelow et al., 2014). In Pakistani population, up to our knowledge no study on genetics of CP has been carried out till date. As such, we focused on TBX22 gene is known to have a role in human palate development. TBX22 is member of T-box gene family that is conserved throughout metazoan evolution. TBX22 is expressed primarily in the palatal shelves and tongue during palatogenesis, and also documented a similar gene expression pattern of mouse Tbx22 gene in E12.5 and E17.5 embryos, suggesting an important role of TBX22 in palatal and tongue development (Braybrook et al., 2001). It has been previously demonstrated that the polymorphisms

Table I. Primers used in this study.

in TBX22 gene makes a significant contribution to prevalence of CP in Thai, Brazilian and North American cohorts. The present was designed to investigate whether TBX22 gene polymorphisms might be responsible for the formation of non-syndromic CP in Pakistani population.

Materials and methods

The current study used TBX22 gene as a candidate gene and accomplished case-control-based study in Pakistani non-syndromic CP cohort. The patients with non-syndromic CP were recruited for this study at Pediatric Surgery Unit of Farooq Hospital (Westood Branch) Lahore, Punjab province, Pakistan. The individuals with non-syndromic CP were enrolled as determined by patient’s records. In the study, we obtained 134 samples following informed consent with local ethical approval. A total of 51 patients (Pak nationality, 45 males and 6 females) and 83 healthy and age-matched controls (62 males and 21 females) with negative family history of CP were enrolled in this study. A detailed phenotype of each patient was got with CP and also taking note of associated features such as presence or absence of ankyloglossia and previous family-history (Figure 1B). In the study, an additional case with a positive family history for isolated CP, having a sibling with ankyloglossia (a condition sometimes associated with cleft palate in X-linked cleft palate, CPX) was enrolled.

For DNA extraction the blood samples from veins in the elbow (2 mL) were collected in EDTA-containing vacutainer tubes and stored at -20 °C until further use. Genomic DNA was extracted from the peripheral blood using Thermo Scientific Gene JET Whole Blood Genomic DNA Purification Mini Kit (Lot no. 00166055). The DNA was quantified by Nanodrop spectrophotometry (Nanodrop 2000 Spectrophotometer, Thermo Scientific, USA).

In the current study, TBX22 gene exons 1, 2, 3, 4 and 8 were selected and amplified by polymerase chain reaction (PCR) using previously reported primers, shown in Table 1 (Suphapeetiporn et al., 2007). PCR was carried out in final volume of 25 µl using 50 ng/µl of genomic DNA as template, 10pMol of each forward-reverse primers, 2.5 mM MgCl2, Buffer 1X (NH4)2 SO4, 100 uM dNTPs mix and 1 U Taq DNA polymerase (Thermo Scientific). The PCR was performed for 35 cycles with 95°C: 30s, 60-50°C: 30s (Touch-Down with -0.5-decrement/cycle), 68°C: 30s with final extension at 68°C for 10 minutes. PCR products were purified by Gene JET gel extraction kit (Thermo Scientific, USA).

A total of five exons of the TBX22 gene were followed by direct sequencing using ABI 3130XL automated sequencer (Applied Biosystem Inc, Faster City, CA). All the obtained sequences were aligned and edited through BioEdit v7.0.9.1 (Hall, 1999). We analyzed exons containing polymorphisms in affected and unaffected individuals with reference sequence accession number NG_008998, NM_001109878.

Result

In the present study, we sequenced five exons of TBX22 gene (MIM#300307) in subjects enrolled in Pediatric Surgery Unit of Farooq Hospital Lahore, Punjab province, Pakistan. We analyzed a total of 134 candidates, including 51 cases and 83 controls with no previous family history of CP. Among the 51 affected individuals, 45 were male and 6 were female individuals. The sequence analysis showed that there were two different sporadic polymorphisms detected in the two exonic regions of TBX22 gene in the CP affected patients. The variations were identified in TBX22 exon 4 and 8, however, we detected no polymorphism in other sequenced exons. To our knowledge, the two variants detected have never been reported previously.

In the study, a total of 7 male (16%) and no female out of 45 and 6 enrolled patients respectively were found mutated in TBX22 gene (Fig. 1B). This would be consistent with the fact that the incidence of CPs caused by an X-linked gene in men is higher than that of CP in woman. A heterozygous condition C673→A (GenBank accession number MG946715) was detected in male only in exon 4 of TBX22, which cause a nonconservative amino acid substitution from proline to glutamine (P180→Q) (Fig. 1A). This polymorphism was detected in 3 male patients with CP having no previous history of clefting. The similar condition was detected in an individual having sibling with another abnormal condition, ankyloglossia (tongue-tie). While the mother of this patient with the same phenotype, no other additional family history. Ankyloglossia has been reported in the majority of X-linked cleft palate (CPX) patients, and it has been conjectured that the tongue is the site of the primary defect. The position of this missense substituion was located at the evolutionary conserved residue within the T-box domain of TBX22 gene originated in various species (Fig. 2), and may therefore, result in impaired DNA binding. The another polymorphism 1117G→T (GenBank accession number MG946716) was detected in 3 males individuals, which caused a nonconservative amino acid substitution from serine to isoleucine (S328→I) in exon 8 (Fig. 1C). The pateints with this polymorphism have no previous family history of CPs. This mutation was located in the carboxy-terminal (c-terminal) outside the T-box domain (Fig. 2).

Discussion

Cleft palate (Palatoschisis) is among the most common congenital malformation caused by abnormal facial development during gestation. Another case cleft lip (cheiloschisis), which can also occur together with CP (CL/P) are birth defects that affect the upper lip and the roof of the mouth respectively. CP has a complex etiology, comprising both genetic and envinmental influences. Several genes with altered functioning during craniofacial development have been discovered are responsible for casuing X-linked CP (Marcano et al., 2004). The identification of the genetic risk factor in CP development involves the expression of multiple genes controlling the complex process of palatogenesis. Non-syndromic CP candidate causing TBX22, which has been reported as a susceptibile gene associated with the inherited X-linked disorder, CP or with anklyloglossia (tongue-tie) (Suphapeetiporn et al., 2007; Marcano et al., 2004).

TBX22–T-box transcription factor is a member of phylogenetically conserved family of proteins that share a common DNA-binding domain, the T-box. The gene has seven exons encodes a 400 amino acids [aa] protein located on chromosome Xq21.1. TBX22 has been previously reported that the mutations result in non-syndromic CP. (Suphapeetiporn et al., 2007). Previous study perfomed in Thai patients with non-synodromic CP revealed four variants in TBX22 gene, two of them were found in two different individuls with positive CP family history and two different individuals were with no family history. Another study carried out by (Marcano et al., 2004) in 256 non-synodromic CP pateints from three ethenic groups, North America, Philippines and Brazalians were screened for polymorphism in TBX22 gene. The study discovered 15 different variants in 238 non-syndromic CP pateints and no polymorphism was identified in 18 syndromic patients in the studied populations. Four of the five coding region polymorphism were present individuals with positive family history and one was discoved in patient with no family history. In our study, we identified two different TBX22 coding region polymorphisms each in exon 4 and 8 in patients affected with non-synodromic CP. A single base substitution C673→A in exon 4 resulting in aa substitution from proline to glutamine (P180→Q) was detected in three patients with no previous family history of clefting. The similar substitution was detected in a patient with positive family history, having sibling with another abnormal condition, ankyloglossia (tongue-tie). Ankyloglossia has been reported in the majority of X-linked cleft palate (CPX) patients, and it has been conjectured that the tongue is the site of the primary defect. The position of this missense substituion is located at the evolutionary conserved residue within the T-box domain of TBX22 gene originated in various species, and may therefore, result in impaired DNA binding (Andreou et al., 2007; Kantaputra et al., 2011). Similar region was discribed with two missense mutations, 359G→A in Thai population and 358C→T in Tunisian population resultng in R120Q and R120W substitutions respectively. Another substitution 452G→T (aa substitution R151L) located within c strand of T box domain in Thai population. The mutations in similar region has been discovered for another T box gene such as TBX19, TBX5 and TBX3 (Marcano et al., 2004). The finding emphasized the importnce of missense mutations in DNA binding domain underlying the non-syndromic CP alone or with ankyloglossia.

The another polymorphism 1117G→T was detected in exon 8 in three males patients with no previous family history of CP or any associated case. The substitution resulting in nonconservative amino acid substitution from serine to isoleucine (S328→I). This mutation was located in the C-terminus outside the T-box domain. The similar region was investigated with two TBX22 mutations 1166 C→A (P389Q) and 1252delG in Thai population (Suphapeetiporn et al., 2007). The mutation discovered in this region possibly affects TBX22 function through the mechanisms involving protein-protein interation or nuclear localization as evidenced in functional analysis of other TBX genes (Fan et al., 2003). Missense mutation in TBX5 casued Holt-Oram syndrome by interfering nuclear localization leading to reduced transcriptional activation (Fan et al., 2003). The present study aimed to investigate the role of variants in TBX22 gene in the development of non-syndromic CP in Pakistani population. The limitation of study was less sample size, however it suggesting the important role of TBX22 holds as a causative factor for non-syndromic CP. Further studies at large scale must be carried out for evaluation of other candidate genes as well as various environmental factors.

Acknowledgment

We thank all patients and their family members for participating in this study. We are grateful to the team at Farooq Hospital (Westwood branch, Lahore) for their kind co-operation. We also thank Higher Education Commission (HEC) of Pakistan for providing research grant for sequencing.

Ethical approval

This research work was approved by the Departmental Ethical Research Committee of the Virtual University of Pakistan, with approval number 006-16.

Statement of conflict of interest

The authors declare no conflict of interest.

References

Andreou, A.M., Pauws, E., Jones, M.C., Singh, M.K., Bussen, M., Doudney, K., Moore, G.E., Kispert, A., Brosens, J.J. and Stanier, P., 2007. Am. J. Hum. Genet., 81: 700-712. https://doi.org/10.1086/521033

Braybrook, C., Doudney, K., Marcano, A.C., Bjornsson, A., Patton, M.A., Goodfellow, P.J., Moore, G.E. and Stanier, P., 2001. Nat. Genet., 29: 179-183. https://doi.org/10.1038/ng730

Chen, Q., Wang, H., Schwender, H., Zhang, T., Hetmanski, J.B., Chou, Y.H.W., Ye, X., Yeow, V., Chong, S.S., Zhang, B., Jabs, E.W., Parker, M.M., Scott, A.F. and Beaty, T.H., 2014. PLoS One., 9: 1-10. https://doi.org/10.1371/journal.pone.0109038

Fan, C., Liu, M. and Wang, Q., 2003. J. biol. Chem., 278: 8780–8785. https://doi.org/10.1074/jbc.M208120200

Hall, T.A., 1999. Nucl. Acid Res., 41: 95–98. https://doi.org/10.1099/00222615-48-1-95

Kantaputra, P.N., Paramee, M., Kaewkhampa, A., Hoshino, A., Lees, M., McEntagart, M., Masrour, N., Moore, G.E., Pauws, E. and Stanier, P., 2011. J. Dent. Res., 90: 450–455. https://doi.org/10.1177/0022034510391052

Marcano, A.C.B., Doudney, K., Braybrook, C., Squires, R., Patton, M.A., Lees, M. Richieri-Costa, A., Lidral, A., Murray, J., Moore, G. and Stanier, P., 2004. J. med. Genet., 41: 68–74.

Murray, J.C., 2002. Clin. Genet., 61: 248–256.

Pegelow, M., Koillinen, H., Magnusson, M., Fransson, I., Unneberg, P., Kere, J., Karsten, A. and Peyrard-Janvid, M., 2014. Cleft Palate Craniofac. J., 51: 49–55. https://doi.org/10.1597/11-220

Satokata, I. and Maas, R., 1994. Nat. Genet., 6: 348-356.

Suphapeetiporn, K., Tongkobpetch, S., Siriwan, P. and Shotelersuk, V., 2007. Clin. Genet., 72: 478-483.

Wang, W., Jiao, X.H., Wang, X.P., Sun, X.Y. and Dong, C., 2016. Genet. Test Mol. Biomark., 20: 297–303. https://doi.org/10.1089/gtmb.2015.0186

Wehby, G.L., Goco, N., Moretti-Ferreira, D., Felix, T., Richieri-Costa, A., Padovani, C., Queiros, F., Guimaraes, C.V.N., Pereira, R., Litavecz, S., Hartwell, T., Chakraborty, H., Javois, L. and Murray, J.C., 2012. BMC Pediatr., 12: 184.